Cefmatilen
Cefmatilen is an orally-active cephalosporin antibiotic. It was developed in Japan and first described in 1992.
In vitro, cefmatilen is highly active against a variety of Gram-positive and Gram-negative bacteria, including Streptococcus pyogenes and Neisseria gonorrhoeae.
